Serum ALT and fibrosis score are surrogate markers to determine liver damage; however, liver biopsy remains the gold standard for diagnosing and characterizing the different stages of NASH (5). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.